protein
| binds negatively charged phospholipid membranes through either Ca2+-dependent or Ca2+-independent/H+-dependent mechanisms |
|
ANXA2, ANXA8, and ANXA9 interacted with proAREG and ADAM17 on the cell surface |
|
ANXA2, ANXA8, ANXA9, play an essential role in the ADAM17-mediated ectodomain shedding of EGFR ligands |
|
HLTF, chromatin-remodeling factor, is a target for the S100A10/ANXA2 heterotetrameric complex |
|
ANXA2 is a well-characterized binding partner for S100A10 |
|
S100A10/ANXA2 not only increases the DNA-binding affinity of HLTF but also anchors HLTF to the nuclear matrix presumably via the interaction of ANXA2 with actin and PIP2 |
|
PLG stimulates airway smooth muscle (ASM) cytokine production in a manner regulated by ANXA2 |
|
ANXA2-S100A10 molecular bridge participates in cell-cell interactions, revealing a hitherto unexplored function of this protein interaction |
|
is a lipid raft-associated trafficking factor for SLC12A1 |
|
plausible new role of ANXA2 in the reduction of PCSK9 protein levels via a translational mechanism |
|
S100A10, and not ANXA2, is the primary plasminogen receptor within the ANXA2-S100A10 complex and contributes to the plasmin-mediated effects that were originally ascribed to ANXA2b |
|
ANXA2 is an autophagy modulator that regulates autophagosome formation by enabling appropriate ATG9A trafficking from endosomes to autophagosomes via actin |
|
ANXA2 directly exerted negative regulation of inflammatory responses through TLR4-initiated TICAM2-TICAM1 pathway occurring on endosomes |
|
novel molecular connection between PODXL and ANXA2: both exert pro-survival effects in neural stem/progenitor cells (NSPs), and PODXL positively regulates ANXA2 expression through the MAPK pathway |
|
KRT8 binds to ANXA2, a protein known to mediate apoptosis as well as the redox pathway |
|
TRIM65 has an essential oncogenic role via ubiquitination of ANXA2 in urothelial carcinoma of the bladder (UCB) pathogenesis |
|
NUDT21 plays a crucial role in bladder cancer progression, at least in part through ANXA2 and LIMK2 which act by alternative polyadenylation |